vs

Side-by-side financial comparison of LXP Industrial Trust (LXP) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $86.7M, roughly 1.6× LXP Industrial Trust). LXP Industrial Trust runs the higher net margin — 33.2% vs -5.3%, a 38.5% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -14.0%). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 0.3%).

LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

LXP vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.6× larger
TOI
$142.0M
$86.7M
LXP
Growing faster (revenue YoY)
TOI
TOI
+55.6% gap
TOI
41.6%
-14.0%
LXP
Higher net margin
LXP
LXP
38.5% more per $
LXP
33.2%
-5.3%
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
0.3%
LXP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LXP
LXP
TOI
TOI
Revenue
$86.7M
$142.0M
Net Profit
$28.8M
$-7.5M
Gross Margin
81.5%
Operating Margin
34.6%
-4.9%
Net Margin
33.2%
-5.3%
Revenue YoY
-14.0%
41.6%
Net Profit YoY
43.0%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LXP
LXP
TOI
TOI
Q4 25
$86.7M
$142.0M
Q3 25
$86.9M
$136.6M
Q2 25
$87.7M
$119.8M
Q1 25
$88.9M
$104.4M
Q4 24
$100.9M
$100.3M
Q3 24
$85.6M
$99.9M
Q2 24
$85.8M
$98.6M
Q1 24
$86.3M
$94.7M
Net Profit
LXP
LXP
TOI
TOI
Q4 25
$28.8M
$-7.5M
Q3 25
$36.3M
$-16.5M
Q2 25
$29.1M
$-17.0M
Q1 25
$19.0M
$-19.6M
Q4 24
$-13.2M
Q3 24
$6.3M
$-16.1M
Q2 24
$5.4M
$-15.5M
Q1 24
$-269.0K
$-19.9M
Gross Margin
LXP
LXP
TOI
TOI
Q4 25
81.5%
Q3 25
82.3%
Q2 25
81.9%
Q1 25
80.7%
Q4 24
85.3%
Q3 24
82.5%
Q2 24
82.0%
Q1 24
82.4%
Operating Margin
LXP
LXP
TOI
TOI
Q4 25
34.6%
-4.9%
Q3 25
50.4%
-5.9%
Q2 25
33.7%
-9.4%
Q1 25
21.8%
-9.5%
Q4 24
-11.9%
Q3 24
7.9%
-13.9%
Q2 24
6.9%
-16.6%
Q1 24
1.0%
-19.0%
Net Margin
LXP
LXP
TOI
TOI
Q4 25
33.2%
-5.3%
Q3 25
41.7%
-12.1%
Q2 25
33.2%
-14.2%
Q1 25
21.4%
-18.8%
Q4 24
-13.1%
Q3 24
7.4%
-16.1%
Q2 24
6.3%
-15.7%
Q1 24
-0.3%
-21.0%
EPS (diluted)
LXP
LXP
TOI
TOI
Q4 25
$-0.04
Q3 25
$0.12
$-0.14
Q2 25
$0.09
$-0.15
Q1 25
$0.06
$-0.21
Q4 24
$-0.14
Q3 24
$0.02
$-0.18
Q2 24
$0.01
$-0.17
Q1 24
$-0.01
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LXP
LXP
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$170.4M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$2.0B
$-15.7M
Total Assets
$3.5B
$164.7M
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LXP
LXP
TOI
TOI
Q4 25
$170.4M
Q3 25
$229.7M
Q2 25
$71.0M
Q1 25
$70.9M
Q4 24
$101.8M
Q3 24
$55.0M
Q2 24
$48.7M
$9.9M
Q1 24
$293.8M
$29.8M
Total Debt
LXP
LXP
TOI
TOI
Q4 25
$1.4B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.6B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
LXP
LXP
TOI
TOI
Q4 25
$2.0B
$-15.7M
Q3 25
$2.1B
$-12.3M
Q2 25
$2.1B
$-9.0M
Q1 25
$2.1B
$5.1M
Q4 24
$2.1B
$3.6M
Q3 24
$2.1B
$15.5M
Q2 24
$2.1B
$29.2M
Q1 24
$2.2B
$41.3M
Total Assets
LXP
LXP
TOI
TOI
Q4 25
$3.5B
$164.7M
Q3 25
$3.7B
$163.6M
Q2 25
$3.7B
$159.8M
Q1 25
$3.8B
$164.0M
Q4 24
$3.8B
$172.7M
Q3 24
$3.9B
$179.2M
Q2 24
$3.9B
$179.6M
Q1 24
$4.2B
$204.5M
Debt / Equity
LXP
LXP
TOI
TOI
Q4 25
0.66×
Q3 25
0.72×
Q2 25
0.72×
Q1 25
0.73×
Q4 24
0.75×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LXP
LXP
TOI
TOI
Operating Cash FlowLast quarter
$188.7M
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
6.56×
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LXP
LXP
TOI
TOI
Q4 25
$188.7M
$3.2M
Q3 25
$63.5M
$-12.6M
Q2 25
$44.3M
$-10.2M
Q1 25
$39.0M
$-5.0M
Q4 24
$211.2M
$4.2M
Q3 24
$64.6M
$819.0K
Q2 24
$38.5M
$-15.7M
Q1 24
$38.9M
$-15.9M
Free Cash Flow
LXP
LXP
TOI
TOI
Q4 25
$2.2M
Q3 25
$-13.2M
Q2 25
$-11.4M
Q1 25
$-5.3M
Q4 24
$2.4M
Q3 24
$417.0K
Q2 24
$-17.5M
Q1 24
$-16.5M
FCF Margin
LXP
LXP
TOI
TOI
Q4 25
1.5%
Q3 25
-9.7%
Q2 25
-9.5%
Q1 25
-5.1%
Q4 24
2.4%
Q3 24
0.4%
Q2 24
-17.7%
Q1 24
-17.4%
Capex Intensity
LXP
LXP
TOI
TOI
Q4 25
0.7%
Q3 25
0.4%
Q2 25
1.0%
Q1 25
0.3%
Q4 24
1.8%
Q3 24
0.4%
Q2 24
1.9%
Q1 24
0.6%
Cash Conversion
LXP
LXP
TOI
TOI
Q4 25
6.56×
Q3 25
1.75×
Q2 25
1.52×
Q1 25
2.05×
Q4 24
Q3 24
10.18×
Q2 24
7.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LXP
LXP

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons